Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Opiant Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 33 | 32 | −1 |
| Shares | 1.86M | 1.81M | −58.7K (−3.2%) |
| Value | $22.3M | $19.4M | −$2.94M (−13.2%) |
New holders (3)
Institutions that held Opiant Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mesirow Financial Investment Management, Inc. | 17,633 | $190.0K | 0.90% |
| Mariner, LLC | 13,550 | $146.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 10,052 | $108.0K | 0.00% |
Sold out (4)
Institutions that held Opiant Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 10,044 | $120.0K |
| Bank of America Corp | 384 | $5.00K |
| CoreCap Advisors, LLC | 266 | $3.00K |
| Citigroup Inc | 20 | $0 |